Development Level

Tbio 16 | 10,625
Tchem 5 | 1,890
Tclin 1 | 602

IMPC Term

abnormal epididymis morphology 1 | 31
abnormal heart morphology 1 | 51
abnormal response to tactile s... 1 | 16
abnormal skin morphology 1 | 23
decreased body length 1 | 108
decreased circulating chloride... 1 | 32
decreased circulating triglyce... 1 | 83
decreased monocyte cell number 1 | 28
enlarged epididymis 1 | 27
enlarged heart 1 | 111
increased circulating chloride... 1 | 43
increased circulating magnesiu... 1 | 10
increased or absent threshold ... 1 | 128
preweaning lethality, complete... 1 | 633
preweaning lethality, incomple... 1 | 260

Disease

ovarian cancer 14 | 8,484
psoriasis 11 | 6,685
Cancer 10 | 2,346
lung cancer 10 | 4,466
osteosarcoma 10 | 7,933
glioblastoma 9 | 5,572
Breast cancer 8 | 3,094
malignant mesothelioma 8 | 3,162
interstitial cystitis 7 | 2,299
medulloblastoma, large-cell 7 | 6,234
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,988
pituitary cancer 6 | 1,972
Multiple myeloma 5 | 1,327
adult high grade glioma 5 | 2,148
lung carcinoma 5 | 2,844
non-small cell lung cancer 5 | 2,798
pancreatic cancer 5 | 2,300
primary pancreatic ductal adenocarcinoma 5 | 1,271
Acquired immunodeficiency syndrome 4 | 164
Mammary Neoplasms 4 | 410
astrocytic glioma 4 | 2,241
astrocytoma 4 | 1,493
atypical teratoid / rhabdoid tumor 4 | 4,369
cutaneous lupus erythematosus 4 | 1,056
invasive ductal carcinoma 4 | 2,950
sonic hedgehog group medulloblastoma 4 | 1,482
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 1,557
Multiple Sclerosis 3 | 498
active Crohn's disease 3 | 918
acute myeloid leukemia 3 | 780
acute quadriplegic myopathy 3 | 1,157
atypical teratoid/rhabdoid tumor 3 | 1,095
dermatomyositis 3 | 933
ependymoma 3 | 2,514
juvenile dermatomyositis 3 | 1,189
oligodendroglioma 3 | 2,849
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
spina bifida 3 | 1,064
Amyotrophic Lateral Sclerosis 2 | 431
Asthma 2 | 349
Carcinoma 2 | 2,147
Human immunodeficiency virus infectious disease 2 | 92
Pick disease 2 | 1,893
Rheumatoid Arthritis 2 | 1,160
Waldenstrons macroglobulinemia 2 | 765
active ulcerative colitis 2 | 477
adrenocortical carcinoma 2 | 1,427
aldosterone-producing adenoma 2 | 664
breast carcinoma 2 | 1,614
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
group 3 medulloblastoma 2 | 2,254
group 4 medulloblastoma 2 | 1,875
hepatocellular carcinoma 2 | 532
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung adenocarcinoma 2 | 2,713
nasopharyngeal carcinoma 2 | 1,056
non-inflammatory breast cancer 2 | 208
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
primitive neuroectodermal tumor 2 | 3,031
tuberculosis and treatment for 6 months 2 | 686
Bipolar Disorder 1 | 266
Bladder Neoplasm 1 | 109
Brain disease 1 | 83
Carcinoma, Transitional Cell 1 | 31
Cardiac arrest 1 | 26
Chronic Lymphocytic Leukemia 1 | 242
Cleft Lip 1 | 91
Cleft palate 1 | 125
Common variable immunodeficiency 1 | 72
Congenital Heart Defects 1 | 37
Conn's syndrome 1 | 22
Craniofacial Abnormalities 1 | 147
Dementia 1 | 129
Frontotemporal dementia 1 | 41
Gaucher disease type 3 1 | 76
Hepatitis B 1 | 103
Hyperaldosteronism 1 | 27
Influenza 1 | 142
Kidney Diseases 1 | 86
Liver Cirrhosis 1 | 101
Lung diseases 1 | 48
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) 1 | 12
Melanoma 1 | 261
Meningitis 1 | 46
Peripheral T-cell lymphoma 1 | 24
Primary cutaneous T-cell lymphoma 1 | 24
Progressive multifocal leukoencephalopathy 1 | 24
Renal Cell Carcinoma 1 | 199
Roberts syndrome 1 | 16
Thrombocytopenia 1 | 105
Thyrotoxicosis 1 | 38
Vitiligo 1 | 71
chronic kidney disease 1 | 90
thrombocytopenia-absent radius syndrome 1 | 15

Tissue

Blood and immune system 22 | 17,995
Cardiovascular System 22 | 17,958
Digestive Tract 22 | 18,473
Endocrine System 22 | 18,512
Female tissues 22 | 18,647
Liver and Pancreas 22 | 18,136
Male tissues 22 | 17,969
Nervous System 22 | 18,561
Respiratory system 22 | 17,484
Urinary Tract 22 | 18,444
Skin and soft tissues 21 | 18,115

Target Family

Non-IDG 15 | 11,971
Transcription Factor 4 | 1,400
Enzyme 1 | 4,146
Ion Channel 1 | 341
Kinase 1 | 634

Grant Application

5P50GM082250-09 22 | 22
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cullin-5 CUL5 Tbio Non-IDG -1.93258 89.1 172
Tumor necrosis factor receptor superfamily member 5 CD40 Tchem Non-IDG -3.44068 3018.0 1385
Bone marrow stromal antigen 2 BST2 Tbio Non-IDG -2.50565 392.8 343
ETS-related transcription factor Elf-3 ELF3 Tbio Transcription Factor -2.34747 243.1 288
Ubiquitin carboxyl-terminal hydrolase 1 USP1 Tchem Enzyme -1.84018 68.5 246
AF4/FMR2 family member 4 AFF4 Tbio Transcription Factor -2.51800 332.1 141
Calcium signal-modulating cyclophilin ligand CAMLG Tbio Non-IDG -1.87317 74.7 118
DNA dC->dU-editing enzyme APOBEC-3G APOBEC3G Tbio Non-IDG -2.74317 642.2 396
RNA-binding protein 8A RBM8A Tbio Non-IDG -3.11419 1352.4 99
Cyclin-dependent kinase 9 CDK9 Tchem Kinase -2.76794 712.3 354